1.           Introduction

1.1         Scope of The Study

1.2         The Insight Partners Research Report Guidance

2.           North America Atrial Fibrillation for Healthcare Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Atrial Fibrillation Market – Market Landscape

4.1         Overview

4.2         Market Segmentation

4.2.1        North America Atrial Fibrillation Market – By Treatment Type

4.2.2        North America Atrial Fibrillation Market – By End User

4.2.3        North America Atrial Fibrillation Market – By Geography

4.3         Pest Analysis

4.3.1        North America – PEST Analysis

5.           North America Atrial Fibrillation Market- Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Rising Number of Patients Suffering with Cardiovascular Diseases

5.2         Restraints

5.2.1        High Cost of Atrial Fibrillation Devices and Procedures

5.3         Key Market Opportunities

5.3.1        Growth Opportunities in The Developing Nations

5.4         Future Trends

5.4.1        Development of Novel Technologies

5.5         Impact Analysis

6.           Atrial Fibrillation Market – North America Analysis

6.1         North America Atrial Fibrillation Market Revenue Forecasts and Analysis

6.2         Market Positioning

6.3         Performance of Key Players

6.3.1        Biosense Webster, Inc. (Johnson & Johnson)

6.3.2        Medtronic

7.           North America Atrial Fibrillation Market Analysis – By Treatment Type

7.1         Overview

7.2         North America Atrial Fibrillation Market, By Treatment Type, 2018 & 2027 (%)

7.3         North America Atrial Fibrillation Market Revenue and Forecasts to 2027, By Product Type (Us$ Mn)

7.4         Non-Pharmacological

7.4.1        Overview

7.5         Non-Pharmacological Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)

7.5.1        MAZE Surgery

7.5.1.1          Overview

7.5.1.2          MAZE Surgery Market Revenue and Forecast to 2027 (US$ Mn)

7.5.2        Catheter Ablation

7.5.2.1          Overview

7.5.2.2          Catheter Ablation Market Revenue and Forecast to 2027 (US$ Mn)

7.5.3        Electric Cardioversion Market

7.5.3.1          Overview

7.5.3.2          Electric Cardioversion Market Revenue and Forecast to 2027 (US$ Mn)

7.6         Pharmacological

7.6.1        Overview

7.6.2        Pharmacological Market Revenue and Forecast to 2027 (US$ Mn)

7.6.3        Anti-Arrhythmic Drugs Market

7.6.3.1          Overview

7.6.3.2          Anti-Arrhythmic Drugs Market Revenue and Forecast to 2027 (US$ Mn)

7.6.4        Anti-Coagulant Drugs Market

7.6.4.1          Overview

7.6.4.2          Anti-Coagulant Drugs Market Revenue and Forecast to 2027 (US$ Mn)

8.           North America Atrial Fibrillation Market Analysis – By End User

8.1         Overview

8.2         North America Atrial Fibrillation Market, By End User, 2018 & 2027 (%)

8.3         North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By End User (Us$ Mn)

8.4         Hospitals

8.4.1        Overview

8.4.2        North America Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

8.5         Ambulatory Surgical Centres

8.5.1        Overview

8.5.2        Ambulatory Surgery Centres Market Revenue and Forecast to 2027 (US$ Mn)

8.6         Cardiac Catheterization Laboratories

8.6.1        Overview

8.6.2        North America Cardiac Catheterization Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

8.7         North America Atrial Fibrillation market

8.7.1        Overview

8.7.2        North America Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)

8.7.3        North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)

8.7.3.1          North America Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.3.2          North America Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.4        North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

8.7.5        North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)

8.7.6        United States

8.7.6.1          US Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)

8.7.6.2          US Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)

8.7.6.2.1          US Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.6.2.2          US Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.6.3          US Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

8.7.7        Canada

8.7.7.1          Canada Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)

8.7.7.2          Canada Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)

8.7.7.2.1          Canada Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.7.2.2          Canada Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.7.3          Canada Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

8.7.8        Mexico

8.7.8.1          Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)

8.7.8.2          Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)

8.7.8.2.1          Mexico Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.8.2.2          Mexico Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.8.3          Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

9.           Atrial Fibrillation Market –Industry Landscape

9.1         Overview

9.1.1        Recent Developments by Players in Atrial Fibrillation Market

10.        Atrial Fibrillation Market- Key Company Profiles

10.1      Boston Scientific Corporation

10.1.1     1.1.1 Key Facts

10.1.2     Business Description

10.1.3     Products and Services

10.1.4     Financial Overview

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2      Medtronic

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Products and Services

10.2.4     Financial Overview

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3      AtriCure, Inc.

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Products and Services

10.3.4     Financial Overview

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4      Biosense Webster, Inc.

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Products and Services

10.4.4     Financial Overview

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5      BOEHRINGER INGELHEIM GMBH

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Products and Services

10.5.4     Financial Overview

10.5.5     SWOT Analysis

10.5.6     Key Developments

10.6      CardioFocus.

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Products and Services

10.6.4     Financial Overview

10.6.5     SWOT Analysis

10.6.6     Key Developments

10.7      Abbott

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Products and Services

10.7.4     Financial Overview

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8      Sanofi

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Products and Services

10.8.4     Financial Overview

10.8.5     SWOT Analysis

10.8.6     Key Developments

10.9      Bristol-Myers Squibb Company

10.9.1     Key Facts

10.9.2     Business Description

10.9.3     Products and Services

10.9.4     Financial Overview

10.9.5     SWOT Analysis

10.9.6     Key Developments

10.10   Biotronik, Inc.

10.10.1  Key Facts

10.10.2  Business Description

10.10.3  Products and Services

10.10.4  Financial Overview

10.10.5  SWOT Analysis

10.10.6  Key Developments

11.        Appendix

11.1      About The Insight Partners

11.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 2.             North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 3.             North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 4.             North America Atrial Fibrillation market Revenue And Forecasts to 2027, By Product type (US$ Mn)

Table 5.             North America Atrial Fibrillation market Revenue And Forecasts to 2027, By technology (US$ Mn)

Table 6.             North America Atrial Fibrillation market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 7.             US Atrial Fibrillation market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 8.             US Atrial Fibrillation market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 9.             US Atrial Fibrillation market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 10.          Canada Atrial Fibrillation market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 11.          Canada Atrial Fibrillation market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 12.          Canada Atrial Fibrillation market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13.          Mexico Atrial Fibrillation market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 14.          Mexico Atrial Fibrillation market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 15.          Mexico Atrial Fibrillation market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 16.          Organic Developments Done By Companies

Table 17.          Inorganic developments done by Companies

Table 18.          Glossary Of Terms, Atrial Fibrillation Market

LIST OF FIGURES

Figure 1.           US Atrial Fibrillation Market, Revenue (US$ Mn), By Country 2018 & 2027

Figure 2.           North America Atrial Fibrillation Market By Product Type, Market Share (%), 2018

Figure 3.           North America Atrial Fibrillation Market By Technology, Market Share (%), 2018

Figure 4.           North America Atrial Fibrillation Market By End User, Market Share (%), 2018

Figure 5.           Atrial Fibrillation Market Segmentation

Figure 6.           North America PEST Analysis

Figure 7.           Atrial Fibrillation Market Impact Analysis Of Drivers & Restraints

Figure 8.           North America Atrial Fibrillation Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 9.           North America Atrial Fibrillation Market, By Product Type, 2018 & 2027 (%)

Figure 10.        Implantable Atrial Fibrillation Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 11.        External Atrial Fibrillation Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.        North America Atrial Fibrillation Market By Technology, 2017 & 2025 (%)

Figure 13.        North America Single Chambered Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.        North America Dual Chambered Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15.        North America Bi-Ventricular Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.        North America Atrial Fibrillation Market By End User, 2018 & 2027 (%)

Figure 17.        North America Hospitals Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.        North America Ambulatory Surgical Centers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.        North America Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.        North America Atrial Fibrillation market revenue Overview, by Country (2017) (us $ mn)

Figure 21.        North America Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        North America Atrial Fibrillation market Revenue And Forecasts to 2027, By Country (%)

Figure 23.        US Atrial Fibrillation market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Canada Atrial Fibrillation market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Mexico Atrial Fibrillation market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Comparative Company Analysis

Figure 27.        Growth Strategies Done by the Companies in the Market, (%)